Find in Library

762 A first-in-human phase 1 clinical study evaluating safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the EDB+FN targeting ADC PYX-201 in participants with advanced solid tumors

oleh: Bin Zhang, Gregory Cote, Marsha Crochiere, Anthony W Tolcher, Shui He, Jason Henry, Alexander I Spira, Shiraj Sen, Judy S Wang, Sharon Wilks, Benedito Carneiro, Frank Yung-Chin Tsai, Sondra Smyrnios, Dipali Unadkat